Our Mission

Trialingo is committed to transform the landscape of clinical trial participation by breaking down the barriers of language. Our vision is not just to connect patients to clinical trials, but to ensure that language is no longer a barrier to life-saving opportunities. We aim to empower cancer patients from every corner of the globe, enabling every individual, regardless of their linguistic background, access to clinical trial information effortlessly. 

The Problem

Minorities comprise 40% of US population; yet make up only 10-15% of clinical trial participants.

FDA 2020 mandate requires diversity plans for all clinical trial sponsors to address a critical need.

Language access is the MAIN barrier for non-English speaking patients to participate in clinical trials.

Language Inclusivity

We see an opportunity to leverage language to address this pain point for clinical trial sponsors

Why Choose Trialingo?

Trialingo is a digital solution that revolutionizes the way cancer patients connect with clinical trials. Our platform offers non-native English speaking cancer patients access to clinical trial opportunities in their preferred language.

PATIENTS
PROVIDERS
SPONSORS